Chronic Graft Versus Host Disease in Intestine
Chronic graft versus host disease affecting the intestine is a serious complication that can develop after a stem cell transplant using donor cells, causing digestive symptoms that may significantly impact daily life and nutrition.
Table of contents
- What Is Chronic Graft Versus Host Disease?
- How Chronic GVHD Affects the Intestine
- Symptoms and Signs
- Risk Factors
- Diagnosis
- Treatment Options
- Managing Nutrition and Diet
- Impact and Long-Term Outlook
What Is Chronic Graft Versus Host Disease?
Graft versus host disease (GVHD) is a complication that can occur after an allogeneic stem cell transplant, which is a procedure where a patient receives blood-forming stem cells from a donor. In this condition, the donated cells (called the graft) view the patient’s body cells (the host) as a threat and attack them[1][2].
There are two main types of GVHD: acute and chronic. Chronic GVHD can appear any time after transplant, though most cases start within the first two years. Unlike acute GVHD, which usually develops within the first 100 days after transplant, chronic GVHD tends to develop more slowly and can affect many different organs and tissues throughout the body[2][5].
Healthcare providers now diagnose the specific type of GVHD based on symptoms and clinical signs, in addition to the timing of symptom onset. Chronic GVHD can evolve from acute GVHD, follow its resolution, or even start in patients without any history of acute GVHD[9].
How Chronic GVHD Affects the Intestine
Chronic GVHD frequently affects the gastrointestinal tract, which includes all parts of the digestive system from the mouth to the rectum. Roughly 33% of patients with chronic GVHD have gastrointestinal involvement[4].
When chronic GVHD affects the intestine, it attacks the lining of the digestive tract. This can cause inflammation and damage that disrupts normal digestion and absorption of nutrients. The condition can affect the food pipe (esophagus), stomach, small intestine, large bowel (intestines), and back passage (rectum)[8].
Intestinal GVHD is particularly important because of its frequency, severity, and impact on the general condition of the patient. The damage to the intestinal lining can prevent or decrease the absorption of nutrients, calories, and hydration, which can lead to weight loss, malnutrition, and other complications[6][16].
Symptoms and Signs
Chronic GVHD in the digestive system can cause a range of symptoms. Patients may complain of oral dryness, mouth ulcers, blistering, or sensitivities to food. These mouth-related symptoms can make eating difficult and uncomfortable[4].
Common intestinal symptoms include nausea, vomiting, and diarrhea. Some patients may experience abdominal pain or cramping. Loss of appetite and difficulty eating are also frequent complaints. These symptoms can range from mild to severe enough to require hospitalization[2][5].
In the esophagus, chronic GVHD can cause narrowing that makes swallowing difficult. Weight loss is another important sign, as the combination of eating difficulties and poor nutrient absorption takes its toll on the body[4].
The severity of chronic gastrointestinal GVHD is assessed by how difficult it is to eat, whether there is narrowing of the esophagus, whether there is weight loss, and its impact on daily activities[4].
Patients have described living with GVHD as a “full-time job,” with the condition bringing about challenges with physical functioning, fatigue, general health, social functioning, and psychological distress including depression and anxiety[14].
Risk Factors
Several factors can increase the risk of developing chronic GVHD. Patients who previously had acute GVHD are at higher risk for developing the chronic form of the disease. Older patients also face increased risk[17].
The type of transplant matters as well. Patients who receive cells from an unrelated donor or from a donor who is not a perfect match have a higher chance of developing chronic GVHD. Those who receive stem cells collected from the bloodstream rather than bone marrow or cord blood also face increased risk[17].
Risk factors for developing GVHD in the gastrointestinal tract specifically depend on the type of chemotherapy received prior to transplant (called the conditioning regimen) and how well-matched the stem cell donor and patient were[4].
Male patients who receive cells from a female donor, particularly if the donor previously bore children, have an elevated risk of chronic GVHD[17].
Diagnosis
Diagnosing chronic GVHD in the intestine requires a thorough evaluation because the symptoms can be confused with other health conditions. Healthcare providers may perform a comprehensive physical exam along with various tests to confirm that symptoms are caused by chronic GVHD and not something else[5].
To properly diagnose gastrointestinal GVHD, multiple tests may be ordered. These can include stool studies to check for infections or other problems, blood tests, and imaging studies[4].
More invasive procedures like endoscopy (examining the upper digestive tract) or colonoscopy (examining the large intestine) may be necessary. During these procedures, doctors can look directly at the intestinal lining and take small tissue samples called biopsies[4].
Biopsies are particularly important for diagnosis because they can help confirm GVHD and rule out other problems such as infection or drug-induced damage that can mimic GVHD symptoms. Without proper testing, patients may be misdiagnosed and treated for GVHD when they actually have a different condition[4].
Treatment Options
Treatment for chronic GVHD affecting the intestine usually includes medications that dampen down the immune system so it doesn’t attack the body’s tissues. The specific treatment depends on how severe the chronic GVHD is and which parts of the body are affected[8].
Steroids (such as prednisone or methylprednisolone) are the first line of treatment for gastrointestinal and liver GVHD. These powerful anti-inflammatory medications help calm the immune response. Patients may take steroids alone or combined with other medications like cyclosporine or tacrolimus[4][8][17].
If steroids fail to control the disease, other medications may be used. These include targeted drugs called ruxolitinib (Jakafi®) and belumosudil (Rezurock®), which have been approved specifically for treating chronic GVHD[4][8].
Additional treatment options that doctors may consider include sirolimus, mycophenolate mofetil (MMF), methotrexate, and monoclonal antibodies. Some patients may benefit from a light treatment called extracorporeal photopheresis (ECP), where white blood cells are collected, treated with light-activated medication, and returned to the patient[8][11].
Chronic GVHD in the intestine can last for many months or even years, which means patients may need to continue treatments for an extended period. Patients with chronic GVHD typically require treatment for three to five years, though some need longer-term or even lifelong medication[17].
Managing Nutrition and Diet
When dealing with chronic GVHD affecting the intestine, maintaining a healthy weight and proper nutrition is critical to helping the body recover. Good nutrition supports immune function and helps the body heal, but intestinal GVHD can make eating and absorbing nutrients extremely difficult[16].
Healthcare providers may recommend following a special GVHD diet that includes bland foods that are easy for the body to digest. This type of diet can help minimize symptoms like diarrhea, nausea, and abdominal pain[18].
For patients with severe symptoms, eating frequent small meals may be easier than three large meals. Avoiding spicy, acidic, or hard-to-digest foods can help reduce irritation. Staying well-hydrated is essential, especially for patients experiencing diarrhea[16].
Some patients may need nutritional supplements or special liquid nutrition formulas to ensure they get enough calories and nutrients. In severe cases where patients cannot eat enough by mouth, doctors may need to provide nutrition through a feeding tube or intravenously[16].
Working with a registered dietitian who specializes in transplant nutrition can be very helpful. They can provide personalized advice on managing eating difficulties and maintaining adequate nutrition despite GVHD symptoms[16].
Impact and Long-Term Outlook
GVHD in the gastrointestinal tract or liver increases the risk of serious complications in patients with acute GVHD. However, for patients with chronic GVHD, intestinal involvement does not appear to increase mortality risk in the same way[4].
That said, chronic GVHD can significantly impact quality of life. Many patients describe the experience as overwhelming, affecting their physical health, emotional well-being, and ability to function socially. The constant management of symptoms and treatments can feel like a full-time job[14].
It’s important for patients to tell their healthcare provider if they’re struggling to cope with chronic GVHD. Medical teams can refer patients to supportive care services, including specialists for physical symptoms as well as mental health support. Having different types of professionals on the care team can make a significant difference in managing this challenging condition[14].
With proper treatment and careful management, many patients with chronic intestinal GVHD can control their symptoms and maintain reasonable quality of life. Regular monitoring for new symptoms is important, as chronic GVHD can affect many areas of the body over time[5][17].
